DE69332718T2 - Enantiomere von carbazolderivaten als 5-ht1-ähnliche agonisten - Google Patents

Enantiomere von carbazolderivaten als 5-ht1-ähnliche agonisten

Info

Publication number
DE69332718T2
DE69332718T2 DE69332718T DE69332718T DE69332718T2 DE 69332718 T2 DE69332718 T2 DE 69332718T2 DE 69332718 T DE69332718 T DE 69332718T DE 69332718 T DE69332718 T DE 69332718T DE 69332718 T2 DE69332718 T2 DE 69332718T2
Authority
DE
Germany
Prior art keywords
pct
agonists
enantiomers
carbazole derivatives
date jul
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69332718T
Other languages
English (en)
Other versions
DE69332718D1 (de
Inventor
Thomas Borrett
John Kitteringham
Alan Porter
Ralph Shipton
Mythily Vimal
Christopher Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ligand UK Ltd
Original Assignee
Vernalis PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis PLC filed Critical Vernalis PLC
Publication of DE69332718D1 publication Critical patent/DE69332718D1/de
Application granted granted Critical
Publication of DE69332718T2 publication Critical patent/DE69332718T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69332718T 1992-12-21 1993-12-16 Enantiomere von carbazolderivaten als 5-ht1-ähnliche agonisten Expired - Lifetime DE69332718T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226530A GB9226530D0 (en) 1992-12-21 1992-12-21 Compounds
PCT/EP1993/003627 WO1994014772A1 (en) 1992-12-21 1993-12-16 Enantiomers of carbazole derivatives as 5-ht1-like agonists

Publications (2)

Publication Number Publication Date
DE69332718D1 DE69332718D1 (de) 2003-04-03
DE69332718T2 true DE69332718T2 (de) 2003-12-04

Family

ID=10726909

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332718T Expired - Lifetime DE69332718T2 (de) 1992-12-21 1993-12-16 Enantiomere von carbazolderivaten als 5-ht1-ähnliche agonisten

Country Status (18)

Country Link
US (2) US5618947A (de)
EP (1) EP0674621B1 (de)
JP (1) JP3364222B2 (de)
KR (1) KR100307001B1 (de)
CN (1) CN1039491C (de)
AT (1) ATE233239T1 (de)
AU (1) AU688748B2 (de)
CA (1) CA2152630C (de)
DE (1) DE69332718T2 (de)
DK (1) DK0674621T3 (de)
ES (1) ES2193151T3 (de)
GB (1) GB9226530D0 (de)
HK (1) HK1012368A1 (de)
MX (1) MX9400035A (de)
NZ (1) NZ259363A (de)
PT (1) PT674621E (de)
WO (1) WO1994014772A1 (de)
ZA (1) ZA939457B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616603A (en) * 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5917054A (en) * 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
GB9723061D0 (en) * 1997-10-31 1998-01-07 Vanguard Medica Ltd Medicaments
CA2310250A1 (en) * 1997-11-14 1999-05-27 August Masaru Watanabe Treatment for alzheimer's disease
GB9808069D0 (en) * 1998-04-16 1998-06-17 Vanguard Medica Ltd Novel processes
GB9817911D0 (en) * 1998-08-17 1998-10-14 Vanguard Medica Ltd New use
FR2841899A1 (fr) * 2002-07-05 2004-01-09 Ppg Sipsy Procede de resolution asymetrique d'un racemique faisant intervenir l'acide diprogulique et utilisation dudit acide comme agent de resolution asymetrique
CN101120002A (zh) * 2005-02-17 2008-02-06 惠氏公司 环烷基稠合的吲哚、苯并噻吩、苯并呋喃和茚衍生物
US20090069399A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched frovatriptan
WO2010073253A1 (en) * 2008-12-22 2010-07-01 Natco Pharma Limited Method for preparing an optically active frovatriptan
WO2010122343A1 (en) * 2009-04-23 2010-10-28 Generics [Uk] Limited A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates
WO2011095803A1 (en) * 2010-02-02 2011-08-11 Generics [Uk] Limited Hplc method for analyzing frovatriptan
WO2012147020A1 (en) * 2011-04-25 2012-11-01 Orchid Chemicals And Pharamceuticals Limited An improved process for the preparation of frovatriptan
EP2816030A1 (de) * 2013-06-20 2014-12-24 Duke Chem, S. A. Verfahren zur Herstellung von Frovatriptan und dessen Enantiomer
GB201312768D0 (en) * 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
CN104402798B (zh) * 2014-10-21 2016-09-14 杭州瑞德化工有限公司 一种3-氨基-1,2,3,4-四氢咔唑的拆分方法
CN104529871A (zh) * 2014-12-22 2015-04-22 青岛正大海尔制药有限公司 一种琥珀酸呋罗曲坦的制备方法
US11405689B2 (en) * 2020-12-09 2022-08-02 Rovi Guides, Inc. Systems and methods for providing recording of a blacked-out media content item

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
JPS6429699A (en) * 1987-07-24 1989-01-31 Mitsubishi Heavy Ind Ltd Recovery method for adiabatic compression heat
US4874399A (en) * 1988-01-25 1989-10-17 Minnesota Mining And Manufacturing Company Electret filter made of fibers containing polypropylene and poly(4-methyl-1-pentene)
JPH0247924A (ja) * 1988-08-08 1990-02-16 Nec Corp 分周回路
GB9113802D0 (en) * 1991-06-26 1991-08-14 Smithkline Beecham Plc Medicaments

Also Published As

Publication number Publication date
KR100307001B1 (ko) 2001-12-28
NZ259363A (en) 1996-12-20
JPH08504790A (ja) 1996-05-21
JP3364222B2 (ja) 2003-01-08
GB9226530D0 (en) 1993-02-17
ATE233239T1 (de) 2003-03-15
ES2193151T3 (es) 2003-11-01
CN1095712A (zh) 1994-11-30
PT674621E (pt) 2003-07-31
US5650426A (en) 1997-07-22
ZA939457B (en) 1995-06-19
DK0674621T3 (da) 2003-06-10
EP0674621B1 (de) 2003-02-26
EP0674621A1 (de) 1995-10-04
CA2152630A1 (en) 1994-07-07
US5618947A (en) 1997-04-08
CA2152630C (en) 2005-07-26
AU5814594A (en) 1994-07-19
KR950704253A (ko) 1995-11-17
CN1039491C (zh) 1998-08-12
DE69332718D1 (de) 2003-04-03
HK1012368A1 (en) 1999-07-30
MX9400035A (es) 1994-07-29
WO1994014772A1 (en) 1994-07-07
AU688748B2 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
DE69332718T2 (de) Enantiomere von carbazolderivaten als 5-ht1-ähnliche agonisten
TW274547B (de)
SE9601598D0 (sv) New process
GB9121456D0 (en) Triazole antifungal agents
MX9602979A (es) Compuestos heterociclicos terapeuticos.
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
DE59304311D1 (de) N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika
NO913023D0 (no) Nye bicykliske aminosubstituerte forbindelsr.
ES8500742A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico
HUT53103A (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
AU639079B2 (en) N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them
FI955707A (fi) Indolijohdannaiset steroidi-5alfa-reduktaasin inhibiittoreina
DE59309898D1 (de) 4-oxo-azetidin-2-sulfonsäureamide und ihre salze, verfahren zu deren herstellung und ihre verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition